Difference between revisions of "Team:Tel-Hai"

 
(31 intermediate revisions by 2 users not shown)
Line 1: Line 1:
−
<html>
+
<html><link rel="stylesheet" type="text/css" href="https://2016.igem.org/Template:Tel-Hai/CSS?action=raw&ctype=text/css" />
−
<link rel="stylesheet" type="text/css" href="https://2016.igem.org/Template:Tel-Hai/CSS?action=raw&ctype=text/css" />
+
<img id="topimg" src="https://static.igem.org/mediawiki/2016/8/8b/T--Tel-Hai--dna.jpg" />
 +
</html> {{Team:Tel-Hai/Header}} <html>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
  
−
<p>test</p>
+
 
−
</html>
+
<p style="text-align: center; margin: 2em 0;">
 +
  <video src="https://static.igem.org/mediawiki/2016/7/79/T--Tel-Hai--video.mp4" style="max-width: 85%;" controls />
 +
</p>
 +
 
 +
<div class="space-equally">
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>Where</span> is the magic happening?</h3>
 +
    </div><div class="back">
 +
      <p>Tel-Hai and MIGAL's labs located in northen Israel</h3>
 +
    </div>
 +
</div></div>
 +
 
 +
 
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>Who</span> are we?</h3>
 +
    </div><div class="back">
 +
      <p>Group of dedicated students and researchers from the fields of biotechnology and biochemistry</p>
 +
    </div>
 +
</div></div>
 +
 
 +
 
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>What</span> is our goal?</h3>
 +
    </div><div class="back">
 +
      <p>Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells</p>
 +
    </div>
 +
</div></div>
 +
 
 +
 
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>Why</span> did we choose Cystic Fibrosis?</h3>
 +
    </div><div class="back">
 +
      <p>This is a "simple" missense mutation, leading to the loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.</p>
 +
    </div>
 +
</div></div>
 +
 
 +
 
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>Why now</span> of all times?</h3>
 +
    </div><div class="back">
 +
      <p>Only recently has genome editing become an affordable and practical tool for <strong>all researchers</strong>, to maximize efficiency in correcting diseases causing mutations.</p>
 +
    </div>
 +
</div></div>
 +
 
 +
 
 +
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 +
  <div class="flipper"><div class="front">
 +
      <h3><span>How</span> can we do it?</h3>
 +
    </div><div class="back">
 +
      <p>Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.</p>
 +
    </div>
 +
</div></div>
 +
</div>
 +
 
 +
 
 +
</div></html>

Latest revision as of 22:30, 19 October 2016

iGEM Tel-Hai 2016






Where is the magic happening?

Tel-Hai and MIGAL's labs located in northen Israel

Who are we?

Group of dedicated students and researchers from the fields of biotechnology and biochemistry

What is our goal?

Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells

Why did we choose Cystic Fibrosis?

This is a "simple" missense mutation, leading to the loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.

Why now of all times?

Only recently has genome editing become an affordable and practical tool for all researchers, to maximize efficiency in correcting diseases causing mutations.

How can we do it?

Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.